reference/24263357

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24263357

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	335
issn	0091-2700 1552-4604
issueIdentifier	3
pageRange	328-335
publicationName	The Journal of Clinical Pharmacology
startingPage	328
bibliographicCitation	Maringwa J, Kågedal M, Hamrén UW, Martin P, Cox E, Hamrén B. Pharmacokinetic–pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA). The Journal of Clinical Pharma. 2014 Nov 20;55(3):328–35. doi: 10.1002/jcph.406.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05d9e8db6352d2309b5a2d4c49825f2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74a8906171ac358d73a71f560f433fec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0675f62052b95a0f1004ae6685ce9e0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f690675a58ad73986f973c5e32a7212 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa1afee15789b373a1a1fa02531a8b80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ff53bf9feaea7c55132ea0b7d225e21
date	2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/25280085 https://doi.org/10.1002/jcph.406
isPartOf	https://portal.issn.org/resource/ISSN/0091-2700 https://portal.issn.org/resource/ISSN/1552-4604 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4646
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pharmacokinetic–pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA)
discusses	http://id.nlm.nih.gov/mesh/M0014072 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0195193 http://id.nlm.nih.gov/mesh/M0015639 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0537319 http://id.nlm.nih.gov/mesh/M0017642 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0000964 http://id.nlm.nih.gov/mesh/M0498675 http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054796 http://id.nlm.nih.gov/mesh/D010078Q000008 http://id.nlm.nih.gov/mesh/D047428Q000008 http://id.nlm.nih.gov/mesh/D018501Q000008 http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D011355Q000008 http://id.nlm.nih.gov/mesh/D011725Q000008 http://id.nlm.nih.gov/mesh/D000072377Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018501Q000097 http://id.nlm.nih.gov/mesh/D005060 http://id.nlm.nih.gov/mesh/D011743 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D010078Q000097 http://id.nlm.nih.gov/mesh/D047428Q000493 http://id.nlm.nih.gov/mesh/D000631 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018501Q000493 http://id.nlm.nih.gov/mesh/D000072377Q000378 http://id.nlm.nih.gov/mesh/D011725Q000493 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D009025 http://id.nlm.nih.gov/mesh/D001711 http://id.nlm.nih.gov/mesh/D010078Q000493 http://id.nlm.nih.gov/mesh/D001172Q000175 http://id.nlm.nih.gov/mesh/D011355Q000493 http://id.nlm.nih.gov/mesh/D008800 http://id.nlm.nih.gov/mesh/D001172Q000097 http://id.nlm.nih.gov/mesh/D011725Q000097 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D007843 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D008390 http://id.nlm.nih.gov/mesh/D017322 http://id.nlm.nih.gov/mesh/D001172Q000201 http://id.nlm.nih.gov/mesh/D016014 http://id.nlm.nih.gov/mesh/D047428Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11671467 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b9dfc2d3341369e2565197a07f91fc1e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223366127

Total number of triples: 76.